Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer

Fig. 2

a Cell viabilities of HGC-27 cells after treated with single HMON@CuS/Gd, HMON@CuS/Gd plus NIR and HMON@CuS/Gd plus NIR on ice, using CCK-8 assay. b LDH leakage of HGC-27 cells after treated with single HMON@CuS/Gd, HMON@CuS/Gd plus NIR and HMON@CuS/Gd plus NIR on ice, using LDH assay. c CCK-8 assay of HGC-27 cells after treated with single HMON@CuS/Gd, HMON@CuS/Gd plus NIR, HMON@CuS/Gd plus NIR on ice or HMON@CuS/Gd plus external heating. d LDH leakage assay of HGC-27 cells after treated with single HMON@CuS/Gd, HMON@CuS/Gd plus NIR, HMON@CuS/Gd plus NIR on ice or HMON@CuS/Gd plus external heating. e The CCK-8 assay of GES-1 cells after incubation with HMON@CuS/Gd NPs for 24 h. f The confocal laser scanning microscopy (CLSM) images of RAW264.7 murine macrophage-like cells after incubation with HMON@CuS/Gd for 24 h. Scale bar: 20 μm. Data are shown as mean ± SD, n = 3. * indicates P < 0.05, *** indicates P < 0.001

Back to article page